Every New York stock exchange trading day I’m posting a daily dividend stock or fund review. I’ll share the three chief qualities of just one equity or fund that could be selected for a dividend stock portfolio I’ve named the Safari to Sweet Success.
This week the portfolio I’m building (my Safari To Sweet Success portfolio) seeks a high-yield and growing stock in the healthcare sector.
That healthcare sector includes ten industries all related to testing, diagnosing and treating what ails us. Healthcare industries are: biotechnology; diagnostics & research; drug manufacturers – major and – specialty & generic; healthcare plans; long-term care facilities; medical care; medical devices; medical distribution; medical supplies.
Today I’m reviewing a large-cap German medical care firm. Its name is Fresenius Medical Care AG & Co. KGaA. Its trading ticker symbol is FMS.
Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. It develops and manufactures a full range of dialysis machines, systems, and disposable products. The company provides dialysis care and related services.
In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products.
The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents.
As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally.
Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.
I use three key data points to gauge the value of any dividend equity or fund like Fresenius Medical Care (FMS):
(1) Price
(2) Dividends
(3) Returns
